North America Biopharmaceuticals Contract Manufacturing Market Size & Outlook
North America biopharmaceuticals contract manufacturing market, 2018-2030 (US$M)
Related Markets
North America biopharmaceuticals contract manufacturing market highlights
- The North America biopharmaceuticals contract manufacturing market generated a revenue of USD 13,745.0 million in 2024.
- The market is expected to grow at a CAGR of 10.8% from 2025 to 2030.
- In terms of segment, mammalian was the largest revenue generating source in 2024.
- Non-mammalian is the most lucrative source segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 13,745.0 million |
| Market revenue in 2030 | USD 25,475.6 million |
| Growth rate | 10.8% (CAGR from 2024 to 2030) |
| Largest segment | Mammalian |
| Fastest growing segment | Non-mammalian |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Mammalian, Non-mammalian |
| Key market players worldwide | Boehringer Ingelheim, Lonza Group Ltd, Innovent Biologics Inc, Rentschler Biopharma SE, JRS Pharma, AGC Inc, AGC Biologics, Probiogen, FUJIFILM Holdings Corp, Toyobo Co Ltd, Samsung Electronics Co Ltd, Thermo Fisher Scientific Inc, WuXi Biologics (Cayman) Inc, AbbVie Inc, Novartis AG ADR, Catalent Inc, ADMA Biologics Inc, Pfizer Inc, Siegfried Holding AG, Cambrex, Binex |
Other key industry trends
- In terms of revenue, North America region accounted for 34.3% of the global biopharmaceuticals contract manufacturing market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 22,789.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopharmaceuticals Contract Manufacturing Market Scope
Biopharmaceuticals Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America biopharmaceuticals contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceuticals contract manufacturing market will help companies and investors design strategic landscapes.
Mammalian was the largest segment with a revenue share of 55.45% in 2024. Horizon Databook has segmented the North America biopharmaceuticals contract manufacturing market based on mammalian, non-mammalian covering the revenue growth of each sub-segment from 2018 to 2030.
North America biopharmaceutical manufacturing market has accounted for the largest share as a consequence of presence of substantial players in the region which are involved in the development and distribution of drugs.
Approvals by the regulatory agencies for biopharmaceuticals are further promoting the regional market growth. For instance, in February 2022, USFDA approved bebtelovimab monoclonal antibody for the treatment against the omicron variant of COVID-19.
North America is home to numerous biopharmaceutical companies, which are outsourcing part of their manufacturing activities to CMOs and CDMO’s based in the region, thereby contributing to the market growth.
Reasons to subscribe to North America biopharmaceuticals contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America biopharmaceuticals contract manufacturing market databook
-
Our clientele includes a mix of biopharmaceuticals contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America biopharmaceuticals contract manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into North America biopharmaceuticals contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America biopharmaceuticals contract manufacturing market size, by country, 2018-2030 (US$M)
North America Biopharmaceuticals Contract Manufacturing Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
